Investing in companies at the forefront of innovation can be exciting, especially in the healthcare sector. Until we can completely eradicate illnesses, there will always be a market for newer and better ways to offer cutting-edge medical care. And corporations that succeed in providing it can also become financially successful, along with their shareholders.

With that in mind, let's look at two healthcare companies that are innovators in their respective niches and could produce market-beating returns in the next 10 years: Exact Sciences (NASDAQ: EXAS) and Intuitive Surgical (NASDAQ: ISRG).

Exact Sciences' goal is to eradicate cancer. Perhaps that's too optimistic, but the company could play a role in reducing cancer deaths through its diagnostic solutions. It developed a product called Cologuard, a non-invasive test for colorectal cancer that is indicated for those 45 or older with an average risk of contracting the disease.

Continue reading

Source Fool.com